Aminocaproic acid Other names: 6-aminohexanoic acid ε-Ahx ε-aminocaproic acid

Chemical formula: C₆H₁₃NO₂  Molecular mass: 131.173 g/mol  PubChem compound: 564

Active ingredient description

Aminocaproic acid is 6-aminohexanoic acid, which acts as an inhibitor of fibrinolysis. The fibrinolysis-inhibitory effects of aminocaproic acid appear to be exerted principally via inhibition of plasminogen activators and to a lesser degree through antiplasmin activity.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
B02AA01 Aminocaproic acid B Blood and blood forming organs → B02 Antihemorrhagics → B02A Antifibrinolytics → B02AA Amino acids
Discover more medicines within B02AA01

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
AMICAR Solution, Tablet FDA, National Drug Code (US) MPI, US: SPL/Old

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 60-32-2
DrugBank Drug: DB00513
KEGG Drug: D00160
PubChem Compound: 564
RxNorm Ingredient: 99
SNOMED-CT Concept: 59882007
Aminocaproic acid (substance)
UNII Identifier: U6F3787206
AMINOCAPROIC ACID

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.